Endovascular aneurysm repair

Medtronic Begins Real-World Post-Market Study of the Valiant Navion Thoracic Stent Graft System in Patients with Thoracic Aortic Dissection

Retrieved on: 
Monday, July 6, 2020
Medical specialties, Circulatory system, Angiology, Vascular surgery, IgG4-related disease, Aortic dissection, RTT, Vascular diseases, Endovascular aneurysm repair, Aorta, Dissection, Thoracic aortic aneurysm

Treatment of aortic dissection is often challenging, especially as patients with fragile aortas have different needs.

Key Points: 
  • Treatment of aortic dissection is often challenging, especially as patients with fragile aortas have different needs.
  • I believe the DISSECT-N study one of the larger prospective aortic dissection repair studies, which includes independent core-lab imaging review will offer critical contemporary insights about TEVAR use in patients with various types of thoracic aortic dissection.
  • An aortic dissection is a serious condition in which the inner layer of the lower aorta is torn, causing the inner and middle layers of the aorta to separate (dissect).
  • Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in approximately 150 countries.

Endologix Issues Correction Notice for Ovation iX Abdominal Stent Graft System

Retrieved on: 
Monday, June 15, 2020
Science, Cardiology, Other Science, Research, Surgery, Health, Medical devices, Other Health, Medical specialties, Angiology, Medicine, Vascular surgery, Endovascular aneurysm repair, Interventional radiology, Evar, Vascular diseases, Polymer, Aneurysm, Ovation

Endologix is committed to replacing Ovation iX with the recently FDA-approved ALTO graft by the end of October 2020.

Key Points: 
  • Endologix is committed to replacing Ovation iX with the recently FDA-approved ALTO graft by the end of October 2020.
  • Ovation iX is differentiated from traditional devices for endovascular aneurysm repair (EVAR) through the use of liquid polymer.
  • In the transition to ALTO, physicians may be considering when to select Ovation iX for their patients given the root cause of polymer leaks.
  • To clarify the decision-making process, Endologix has updated the labelling of the Ovation iX platform with the following warning: Polymer leaks are a unique potential risk of the Ovation iX device platform that have been reported post-market.

COVID-19 Impact and Recovery Analysis- Aortic Stent Grafts Market 2020-2024 | Rising Preference for EVAR to Boost Growth | Technavio

Retrieved on: 
Thursday, June 11, 2020
Medical Supplies, Medical devices, Health, Surgery, General Health, Cardiology, Medical specialties, Medicine, Interventional radiology, Angiology, Vascular surgery, Vascular diseases, Endovascular aneurysm repair, Stent, Evar, Aneurysm

View the full release here: https://www.businesswire.com/news/home/20200610005672/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200610005672/en/
    Technavio has announced its latest market research report titled Global Aortic Stent Grafts Market 2020-2024 (Photo: Business Wire).
  • Market estimates include pre- and post-COVID-19 impact on the Aortic Stent Grafts Market Download free sample report
    The market is concentrated, and the degree of concentration will accelerate during the forecast period.
  • Rising preference for Endovascular Aneurysm Repair (EVAR) procedures has been instrumental in driving the growth of the market.
  • https://www.technavio.com/report/report/aortic-stent-grafts-market-indus...
    Aortic Stent Grafts Market 2020-2024: Segmentation
    Aortic Stent Grafts Market is segmented as below:

Global Aortic Stent Grafts Market 2020-2024 | Evolving Opportunities with Becton, Dickinson and Co. and Cardinal Health Inc. | Technavio

Retrieved on: 
Wednesday, April 29, 2020
Health, Surgery, Cardiology, Medical devices, Medical specialties, Medicine, Vascular surgery, Interventional radiology, Angiology, Endovascular aneurysm repair, Aortic aneurysm, Stent, Cardiac surgery

The aortic stent grafts market is poised to grow by USD 690.09 million during 2020-2024, progressing at a CAGR of over 5% during the forecast period.

Key Points: 
  • The aortic stent grafts market is poised to grow by USD 690.09 million during 2020-2024, progressing at a CAGR of over 5% during the forecast period.
  • In addition, the technological advances are anticipated to boost the growth of the aortic stent grafts market.
  • Thus, the rising preference for MI EVAR to treat aortic aneurysms is expected to drive market growth during the forecast period.
  • Aortic Stent Grafts Market Application Outlook (Revenue, USD mn, 2020-2024)
    Aortic Stent Grafts Market Geographic Landscape Outlook (Revenue, USD mn, 2020-2024)

FDA Grants NEXUS™ Aortic Arch Stent Graft System Breakthrough Designation

Retrieved on: 
Monday, April 20, 2020
Research, Technology, Medical devices, Surgery, Hospitals, FDA, Other Technology, Cardiology, Health, Science, Medical specialties, Medicine, Angiology, Interventional radiology, Vascular surgery, Stent, Cardiac surgery, Vascular diseases, Endovascular aneurysm repair, Thoracic aortic aneurysm

Endospan , a pioneer in off-the-shelf endovascular repair of aortic arch disease was recently granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the NEXUS Aortic Arch Stent Graft System.

Key Points: 
  • Endospan , a pioneer in off-the-shelf endovascular repair of aortic arch disease was recently granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the NEXUS Aortic Arch Stent Graft System.
  • The designation of NEXUSTM Aortic Arch Stent Graft System as a breakthrough device acknowledges the unmet need in this patient population and the potential for improvements over current standard treatments.
  • The NEXUS Aortic Arch Stent Graft System is uniquely engineered to address this significant area of unmet clinical need.
  • Endospans NEXUSTM Aortic Arch Stent Graft System is the first endovascular off-the-shelf system with CE Mark to treat a greatly underserved group of patients diagnosed with a dilative lesion in, or near the aortic arch.

CryoLife Receives CE Mark for E-vita Open NEO™ Hybrid Stent Graft

Retrieved on: 
Wednesday, March 4, 2020
Medical specialties, Medicine, Angiology, Interventional radiology, Cardiac surgery, Aorta, Vascular surgery, Aortic arch, Stent, Endovascular aneurysm repair, Thoracic aortic aneurysm

ATLANTA, March 4, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark for the E-vita Open NEO, a hybrid stent graft system for the treatment of aortic arch disease.

Key Points: 
  • ATLANTA, March 4, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark for the E-vita Open NEO, a hybrid stent graft system for the treatment of aortic arch disease.
  • It is anticipated that the E-vita Open NEO often will be used in combination with JOTEC's thoracic stent graft offering, E-nya.
  • "We are pleased to have received CE Mark for E-vita Open NEO, our newest hybrid stent graft technology for aortic arch and descending thoracic aorta repair.
  • Arjang Ruhparwar in Essen, Germany commented, "15 years ago, the introduction of the Evita Open Plus hybrid stent graft changed conventional open aortic arch surgery.

Global Aortic Stent Grafts Market 2020-2024 | Evolving Opportunities with Cook group Inc. and CryoLife Inc. | Technavio

Retrieved on: 
Thursday, January 9, 2020
Health, Surgery, Medical Supplies, Medical devices, Medical specialties, Medicine, Angiology, Vascular surgery, Interventional radiology, Vascular diseases, Endovascular aneurysm repair, Aortic aneurysm, Evar, Aneurysm, Stent

Technavio has been monitoring the global aortic stent grafts market since 2014 and the market is poised to grow by USD 690.09 million during 2020-2024 at a CAGR of over 5% during the forecast period.

Key Points: 
  • Technavio has been monitoring the global aortic stent grafts market since 2014 and the market is poised to grow by USD 690.09 million during 2020-2024 at a CAGR of over 5% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20200109005361/en/
    Technavio has announced its latest market research report titled global aortic stent grafts market 2020-2024.
  • (Graphic: Business Wire)
    Read the 153-page research report with TOC on "Aortic Stent Grafts Market Analysis Report by Geography (Asia, Europe, North America, and ROW), by Application (AAA and TAA), and Segment Forecasts, 2020-2024".
  • The rising preference for MI endovascular aneurysm repair (EVAR) to treat aortic aneurysms and technological advances are anticipated to boost the growth of the market.

Global Endovascular Aneurysm Repair (EVAR) Market by Indication, Product, Gender, Age, End-user & Region - Forecast to 2024

Retrieved on: 
Tuesday, November 26, 2019
Medical specialties, Angiology, Cardiovascular system, Vascular surgery, Vascular diseases, Interventional radiology, Endovascular aneurysm repair, Evar, Aneurysm

DUBLIN, Nov. 26, 2019 /PRNewswire/ -- The "Endovascular Aneurysm Repair (EVAR) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 26, 2019 /PRNewswire/ -- The "Endovascular Aneurysm Repair (EVAR) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.
  • The global endovascular aneurysm repair market is expected to grow at a CAGR of 8% during 2019-2024.
  • How has the global endovascular aneurysm repair market performed so far and how will it perform in the coming years?
  • What is the structure of the global endovascular aneurysm repair industry and who are the key players?

Global Endovascular Aneurysm Repair (EVAR) Markets to 2024: Industry Trends, Share, Size, Growth & Opportunity - ResearchAndMarkets.com

Retrieved on: 
Monday, November 25, 2019
Medical devices, Health, Medical specialties, Angiology, Medicine, Vascular surgery, Interventional radiology, Vascular diseases, Endovascular aneurysm repair, Evar, Aneurysm

The "Endovascular Aneurysm Repair (EVAR) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Endovascular Aneurysm Repair (EVAR) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.
  • This report provides a deep insight into the global endovascular aneurysm repair market covering all its essential aspects.
  • How has the global endovascular aneurysm repair market performed so far and how will it perform in the coming years?
  • What is the structure of the global endovascular aneurysm repair industry and who are the key players?

Global Endovascular Aneurysm Repair Market Report 2019-2025 with Company Analysis of LeMaitre Vascular, Medtronic, Endologix, Terumo, Microport Scientific

Retrieved on: 
Thursday, October 24, 2019
Medical specialties, Angiology, Cardiovascular system, Vascular surgery, Vascular diseases, Aortic aneurysm, IgG4-related disease, Thoracic aortic aneurysm, Cardiac surgery, Endovascular aneurysm repair, Abdominal aortic aneurysm, Aneurysm

The Endovascular Aneurysm Repair Market is likely to cross US$ 4 Billion mark by the end of the year 2025.

Key Points: 
  • The Endovascular Aneurysm Repair Market is likely to cross US$ 4 Billion mark by the end of the year 2025.
  • Basically, there are three kinds of aortic aneurysm covered in the report; abdominal aortic aneurysm (AAA), Thoracic Aortic Aneurysm (TAA), and Thoracoabdominal Aortic Aneurysm (TAAA).
  • Global Vascular Graft Market: In this report, the publisher has fragmented the market by the position of Aortic Aneurysm Repair; Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA), and Thoracoabdominal Aortic Aneurysm (TAAA).
  • In this report, the researchers have comprehensively showcased the number of procedure by each segment; Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA), and Thoracoabdominal Aortic Aneurysm (TAAA).